Anne M Filppula

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 6

Top Topics

Chronic Myeloid Leukemia

Antiplatelet Therapy

Small Cell Lung Cancer

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Basic & clinical pharmacology & toxicology

Scientific reports

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen, Mikko Holmberg, Johanna I Kiiski, Outi Lapatto-Reiniluoto, Anne M Filppula, Mika Kurkela, Janne T Backman, Mikko Niemi
Ticagrelor increases exposure to the breast cancer resistance protein substrate rosuvastatin. Clinical pharmacology and therapeutics (2023)
Marie-Noëlle Paludetto, Mika Kurkela, Helinä Kahma, Janne T Backman, Mikko Niemi, Anne M Filppula
Hydroxychloroquine is metabolized by CYP2D6, CYP3A4, and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A in vitro . Drug metabolism and disposition: the biological fate of chemicals (2022)
Aleksi Tornio, Anne M Filppula, Janne T Backman
Translational aspects of cytochrome P450-mediated drug-drug interactions: A case study with clopidogrel. Basic & clinical pharmacology & toxicology (2021)
Helinä Kahma, Anne M Filppula, Terhi Launiainen, Jenni Viinamäki, Mikko Neuvonen, Eric A Evangelista, Rheem A Totah, Janne T Backman
Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8. Drug metabolism and disposition: the biological fate of chemicals 47 (4) (2019)
Anne M Filppula, Rezvan Parvizi, André Mateus, Pawel Baranczewski, Per Artursson
Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations. Scientific reports 9 (1) (2019)
Helinä Kahma, Anne M Filppula, Mikko Neuvonen, E Katriina Tarkiainen, Aleksi Tornio, Mikko T Holmberg, Matti K Itkonen, Moshe Finel, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions . Drug metabolism and disposition: the biological fate of chemicals 46 (2) (2017)
Anne M Filppula, Pertti J Neuvonen, Janne T Backman
In vitro assessment of time-dependent inhibitory effects on CYP2C8 and CYP3A activity by fourteen protein kinase inhibitors. Drug metabolism and disposition: the biological fate of chemicals 42 (7) (2014)